Performance analysis of IO Biotech (IOBT)
Annual Return
Over the past 3 years, IOBT has had an average annual return of -71.33%, underperforming the benchmark SPY, which returned +17.66% annual.
Since Nov 5, 2021, IOBT has had an average annual return of -71.80%, underperforming the benchmark SPY, which returned +9.26% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -90.23% | -33.84% | -51.04% | -18.30% | -64.05% | -59.11% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -52.44% | +20.54% | -82.96% | -90.23% | |||||||||
| 2025 | -2.21% | +5.04% | +15.23% | -10.92% | +46.29% | -2.09% | +60.47% | -29.12% | -77.03% | +186.64% | -30.83% | -15.43% | -33.84% |
| 2024 | -7.41% | -8.09% | +8.12% | -15.57% | -19.19% | -0.80% | +15.37% | +11.01% | -29.96% | +18.03% | -28.16% | +3.34% | -51.04% |
| 2023 | +20.41% | -8.31% | -26.19% | +1.84% | +8.93% | -6.02% | -5.84% | +0% | -23.38% | -39.18% | +36.50% | +60.56% | -18.30% |
| 2022 | +33.60% | -16.02% | -26.18% | +36.79% | -33.39% | -3.31% | -17.12% | -14.23% | -18.34% | -8.89% | +17.81% | -20.93% | -64.05% |
| 2021 | -40.38% | -31.42% | -59.11% |
Drawdown analysis of IO Biotech (IOBT)
The maximum drawdown for the IOBT was -99.62%, occurring on Mar 31, 2026. This drawdown has not yet recovered.
The current IOBT drawdown is -99.62%.
Since Nov 5, 2021 IOBT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.62% | Nov 5, 2021 | 1102 | Mar 31, 2026 | Ongoing | Ongoing | Ongoing |